Abstract

Hypothalamic inflammation plays an important role in disrupting feeding behavior and energy homeostasis as well as in the pathogenesis of obesity and diabetes. Here, we show that pyruvate dehydrogenase kinase (PDK)-2 plays a role in hypothalamic inflammation and its sequelae in mouse models of diabetes. Cell type-specific genetic ablation and pharmacological inhibition of PDK2 in hypothalamic astrocytes suggest that hypothalamic astrocytes are involved in the diabetic phenotype. We also show that the PDK2-lactic acid axis plays a regulatory role in the observed metabolic imbalance and hypothalamic inflammation in mouse primary astrocyte and organotypic cultures, through the AMPK signaling pathway and neuropeptidergic circuitry governing feeding behavior. Our findings reveal that PDK2 ablation or inhibition in mouse astrocytes attenuates diabetes-induced hypothalamic inflammation and subsequent alterations in feeding behavior.

Highlights

  • Hypothalamic inflammation plays an important role in disrupting feeding behavior and energy homeostasis as well as in the pathogenesis of obesity and diabetes

  • To investigate whether PDK2 is expressed in neurons differentially, we performed immunostaining of PDK2 and AgRP or POMC in serial brain sections isolated

  • Our findings demonstrate a critical role that astrocyte-specific PDK2 plays in the hypothalamus in regulating metabolic and inflammatory pathways that contribute to the hypothalamic pathology of altered feeding behavior associated with diabetes

Read more

Summary

Introduction

Hypothalamic inflammation plays an important role in disrupting feeding behavior and energy homeostasis as well as in the pathogenesis of obesity and diabetes. Microglia[5,15], astrocytes[7,16], perivascular macrophages[17], and neurons[18] are the key cell types that contribute to the hypothalamic inflammation associated with metabolic disorders. Microglia, as first-responder cells, play an important role in hypothalamic inflammation and neuronal circuit alterations, promoting obesity and subsequent metabolic complications[5,15,20,21]. Our previous studies have identified PDKs as an important regulator of immune cell metabolism and have suggested its widespread expression[34,35] and critical role in inflammation in the peripheral nervous system. Astrocyte metabolic alterations are critical for their inflammatory activation/phenotype[29,30], the contribution of astrocyte metabolic reprogramming to hypothalamic inflammation and related metabolic disorders, such as diabetes, remains to be explored

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.